von Hippel-Lindau Disease
"von Hippel-Lindau Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.
| Descriptor ID |
D006623
|
| MeSH Number(s) |
C10.562.925 C14.907.077.925
|
| Concept/Terms |
von Hippel-Lindau Disease- von Hippel-Lindau Disease
- von Hippel Lindau Disease
- Familial Cerebello-Retinal Angiomatosis
- Angiomatoses, Familial Cerebello-Retinal
- Angiomatosis, Familial Cerebello-Retinal
- Cerebello-Retinal Angiomatoses, Familial
- Cerebello-Retinal Angiomatosis, Familial
- Familial Cerebello Retinal Angiomatosis
- Familial Cerebello-Retinal Angiomatoses
- Hippel-Lindau Disease
- Hippel Lindau Disease
- Lindau Disease
- von Hippel-Lindau Syndrome
- Syndrome, von Hippel-Lindau
- von Hippel Lindau Syndrome
- Angiomatosis Retinae
- Retinae, Angiomatosis
- VHL Syndrome
- Syndrome, VHL
- Syndromes, VHL
- VHL Syndromes
- Cerebelloretinal Angiomatosis, Familial
- Angiomatoses, Familial Cerebelloretinal
- Angiomatosis, Familial Cerebelloretinal
- Cerebelloretinal Angiomatoses, Familial
- Familial Cerebelloretinal Angiomatoses
- Familial Cerebelloretinal Angiomatosis
- Lindau's Disease
- Lindau's Diseases
- Lindaus Disease
|
Below are MeSH descriptors whose meaning is more general than "von Hippel-Lindau Disease".
Below are MeSH descriptors whose meaning is more specific than "von Hippel-Lindau Disease".
This graph shows the total number of publications written about "von Hippel-Lindau Disease" by people in this website by year, and whether "von Hippel-Lindau Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2007 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "von Hippel-Lindau Disease" by people in Profiles.
-
Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature. Childs Nerv Syst. 2023 05; 39(5):1361-1363.
-
Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer. 2022 02 01; 128(3):435-446.
-
Use of optical coherence tomography angiography in the diagnosis of small retina lesions in Von Hippel-Lindau disease. Eye (Lond). 2020 12; 34(12):2345-2346.
-
Efficacy of Retinal Lesion Screening in Von Hippel-Lindau Patients With Widefield Color Fundus Imaging Versus Widefield FA. Ophthalmic Surg Lasers Imaging Retina. 2019 11 01; 50(11):e260-e265.
-
In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease. J Clin Endocrinol Metab. 2018 04 01; 103(4):1631-1638.
-
A histopathological connection between a fatal endolymphatic sac tumour and von Hippel-Lindau disease from 1960. J Laryngol Otol. 2018 Jan; 132(1):75-78.
-
CNS hemangioblastomatosis in a patient without von Hippel-Lindau disease. CNS Oncol. 2017 04; 6(2):101-105.
-
Neurological Management of Von Hippel-Lindau Disease. Neurologist. 2016 Sep; 21(5):73-8.
-
Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease. Nat Rev Clin Oncol. 2016 09; 13(9):537-49.
-
Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer. 2007 Jun; 14(2):463-71.